home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Caprotec Bioanalytics GmbH announces collaborative research agreement with Bayer CropScience


Berlin, Germany and Burlington, Massachusetts, USA
December 6, 2011

caprotec bioanalytics GmbH announced today that it has initiated a research collaboration with Bayer CropScience. Under the collaborative research agreement, caprotec will use its proprietary CCMS (Capture Compound Mass Spectrometry) technology to profile the interactions of one of Bayer CropScience's undisclosed new active ingredients in the relevant biological system.

"We are very excited about the opportunity to collaborate with Bayer CropScience applying our CCMS technology in the field of agrochemicals to discover the target protein and the mode of action, allowing subsequent structural optimization," said Dr. Hubert Koster, CEO of caprotec.

"CCMS permits the direct isolation of the agrochemical-specific subset of proteins from a complex biological sample in an unbiased way. Due to the functional enrichment of the proteins and their covalent attachment to the Capture Compounds, CCMS also identifies low abundant and weakly interacting proteins. Direct interaction of the small molecules to the proteins can be confirmed as well. The CCMS process is carried out in solution so that even membrane proteins like ion channels and GPCRs from whole intact cells can be identified. CCMS fills a crucial technological gap in the important field of functional proteomics," continued Dr. Koster.

"We were impressed by the results of a CCMS pilot study, and are now looking forward to a continuation of our successful collaboration with caprotec," stated Dr. Alexander Klausener, Head of Research, Bayer CropScience,

caprotec bioanalytics is headquartered in Berlin, Germany with a US subsidiary in Burlington, MA. The company focuses on the commercialization of its proprietary Capture Compound Mass Spectrometry(TM) (CCMS) technology. The core of the CCMS technology consists of small tri-functional molecules called Capture Compounds (CCs). They enable a targeted isolation of proteins directly from complex biological samples in solution. After isolation the captured proteins including membrane proteins are identified by mass spectrometry. Providing a state-of-the-art platform for the isolation and analysis of proteins from complex mixtures, the CCMS technology has enormous potential in proteomics, drug development and the development of protein biomarkers. The technology is protected by a broad patent portfolio. The company is supported by an international scientific advisory board including one Nobel Laureate.



More news from:
    . Caprotec Bioanalytics GmbH
    . Bayer CropScience AG


Website: http://www.caprotec.com

Published: December 6, 2011

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section


Copyright @ 1992-2025 SeedQuest - All rights reserved